Search PubMed⌕ Search

Biomedical subjects

H Kiat

Publications and source records attributed to H Kiat.

68 records · Page 4Linked to original sources
PubMed1990

Quantitative analysis of tomographic stress thallium-201 myocardial scintigrams: a multicenter trial.

The accuracy of the previously developed and validated Cedars-Sinai Medical Center (CSMC) computer program for quantitative analysis of thallium-201 (201TI) stress myocardial tomograms was assessed in a multicenter trial consisting of 242 patients with coronary angiography and 76 with a low likelihood (LL) of coronary artery disease (CAD) involving various cameras, computers, and operators. The program utilized gender-matched normal limits developed from 35 LL patients at CSMC. The multicenter results as compared to those of 168 patients from CSMC were not significantly different with respect to the overall sensitivities (94% versus 95%) and specificities (44% versus 56%) for identification of CAD and normalcy rates which were determined in LL patients (82% for both) and with respect to identification of individual diseased arteries. The results indicate that our method for quantifying tomographic 201TI stress scintigrams utilizing standard normal limits can be applied at other institutions by different operators, using a variety of cameras and computers, with similar accuracy to that currently obtained at our institution.

Coronary Disease↗
PubMed1989

Radionuclide imaging of myocardial perfusion and viability in assessment of acute myocardial infarction.

Technical advances in radionuclide imaging have important implications for the management of patients with acute myocardial infarction. Single-photon emission computerized tomography with thallium 201 (TI-201) offers greater accuracy than planar imaging in detecting, localizing and sizing myocardial perfusion defects. Use of single-photon emission computerized tomography with TI-201 should allow for a more accurate assessment of prognosis after myocardial infarction. A new radiopharmaceutical, technetium 99-m methoxyisobutyl isonitrile, provides a number of advantages over TI-201, including higher quality images, lack of redistribution, and the ability to assess first-pass ventricular function. Applications of TI-201 and technetium 99-m methoxyisobutyl isonitrile include assessment of arterial patency and myocardial salvage immediately after thrombolytic therapy, detection of resting ischemia after thrombolytic therapy, targeting of subsets of patients for further intervention, and predischarge assessment to predict the future course of patients after an acute myocardial infarction.

Coronary Circulation↗
PubMed1989

Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods.

To compare stress/rest technetium 99m methoxy isobutyl isonitrile (Tc-MIBI) with stress redistribution thallium 201(T1-201) myocardial perfusion imaging, 36 patients were studied by single photon emission computerized tomography (SPECT) and planar methods. For SPECT, overall sensitivities for identification of patients with coronary artery disease were 93% (14/15) by Tc-MIBI and 80% (12/15) by TI-201 (p = NS). For planar methods, overall sensitivities were 73% (11/15) by both TI-201 and Tc-MIBI. Overall specificity was 75% (3/4 patients with normal coronary arteries) for both tracers with SPECT and Tc-MIBI by planar imaging and was 50% for planar TI-201 (p = NS). The normalcy rates for overall identification of coronary artery disease were determined in 17 patients with a low likelihood of disease. For SPECT, normalcy rates were 100% by Tc-MIBI and 77% by TI-201 (p = NS). For planar, they were 94% by Tc-MIBI and 88% by TI-201 (p = NS). Vessel sensitivities in the 35 stenosed coronary arteries (greater than or equal to 50% stenosis) for SPECT were 87% by Tc-MIBI and 77% by TI-201 (p = NS). For planar, the vessel sensitivities were 60% by Tc-MIBI and 54% by TI-201 (p = NS). For both tracers, the SPECT vessel sensitivities were significantly higher (p less than 0.005) than planar vessel sensitivities. The vessel specificities in 22 coronary vessels with less than 50% stenosis were 86% by SPECT Tc-MIBI and TI-201, 80% by planar Tc-MIBI and 73% by planar TI-201 (p = NS, SPECT vs planar, Tc-MIBI vs TI-201). Regarding myocardial segmental agreement, for the presence of stress defects the agreement was 91% for the 720 SPECT segments and 95% for the 540 planar segments. For severity of stress defects based on semiquantitative visual scoring, the exact agreement was 87% for SPECT and 80% for planar. For the pattern of reversibility in myocardial segments with stress defects, the agreement was 97% for SPECT and 91% for planar. This study demonstrated that Tc-MIBI and TI-201 correlate well on both planar and SPECT images with respect to the identification of patients with coronary artery disease, identification of disease in individual coronary arteries, the presence and severity of perfusion defects, and the assessment of defect reversibility. Furthermore, SPECT Tc-MIBI was shown to be superior to planar Tc-MIBI for the identification of individual diseased vessels.

Adult↗
PubMed1988

Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability.

Twenty-one patients were studied who underwent thallium-201 stress-redistribution single photon emission computed tomography (SPECT) both before and after coronary artery bypass grafting (n = 15) or transluminal coronary angioplasty (n = 6). All patients underwent thallium imaging 15 min, 4 h and late (18 to 72 h) after stress as part of the preintervention thallium-201 scintigram. In a total of 201 tomographic myocardial segments with definite post-stress thallium-201 perfusion defects in which the relevant coronary arteries were subsequently successfully reperfused, the 4 h redistribution images did not predict the postintervention scintigraphic improvement: 67 (85%) of the 79 4 h reversible as well as 88 (72%) of the 122 4 h nonreversible segments improved (p = NS). The 18 to 72 h late redistribution images effectively subcategorized the 4 h nonreversible segments with respect to postintervention scintigraphic improvement: 70 (95%) of the 74 late reversible segments improved after intervention, whereas only 18 (37%) of the 48 late nonreversible segments improved (p less than 0.0001). The frequency of late reversible defects and the frequency of postrevascularization improvement of late nonreversible defects are probably overestimated by this study because of referral biases. The cardiac counts and target to background ratios from late redistribution studies resulted in satisfactory cardiac images for visual interpretation. For optimal assessment of the extent of viable myocardium by thallium-201 scintigraphic studies, late redistribution imaging should be performed when nonreversible defects are observed on 4 h redistribution images.

Aged↗
PubMed1985

Controlled trial of enalapril in congestive cardiac failure.

Twenty five patients with chronic congestive cardiac failure had enalapril (n = 13) or placebo (n = 12) added to their existing regimen of digoxin and frusemide in a randomised double blind trial. Four hours after the first 5 mg dose, the enalapril group showed significant falls in blood pressure, heart rate, and concentrations of plasma angiotensin II, angiotensin converting enzyme, and noradrenaline. During the 12 week trial heart failure became worse in one enalapril treated patient (8%) and in seven placebo treated patients (58%). There were no significant changes in cardiac ejection fraction or exercise duration in either group. Plasma noradrenaline response to graded exercise and maximum exercise rate-pressure product were significantly reduced after four and 12 weeks of active treatment but unchanged with placebo treatment. There was a sustained increase in plasma potassium and a slight rise in plasma creatinine in the enalapril group. Plasma concentrations of the active drug, enalaprilate, were dose related and log enalaprilate correlated significantly with percentage of plasma angiotensin converting enzyme activity (r = -0.66). Enalapril was well tolerated and produced no adverse effects. The drug appears to be superior to placebo and offers considerable promise for the treatment of this condition.

Angiotensin II↗
PubMed1984

Enalapril for severe congestive heart failure. A double-blind study.

The effects of the new, orally administered converting-enzyme inhibitor, enalapril (MK-421), were studied in 12 ambulatory patients with severe cardiac failure who were also receiving digoxin and diuretic agents. The study was double-blind, parallel, placebo-controlled and randomized. The clinical characteristics and pretreatment exercise performance were similar in the two groups of patients. All vasodilator drugs had been withdrawn two weeks before the start of the trial. At 12 weeks, the patients receiving enalapril showed a significant improvement in the functional class of the disease, exercise time (P less than 0.01), and maximum workload achieved, and experienced relief of symptoms. Blood pressure fell in patients receiving active treatment suggesting a reduction of afterload. Left ventricular ejection fraction was unchanged in enalapril-treated patients, but fell in patients on placebo (P less than 0.001). Enalapril was well tolerated without apparent adverse effects. It was effective when used with digoxin and diuretic agents in the treatment of severe cardiac failure, and its efficacy was maintained throughout 12 weeks of therapy.

Administration, Oral↗
PubMedDate not supplied

Rest and treadmill exercise first-pass radionuclide ventriculography: validation of left ventricular ejection fraction measurements.

BACKGROUND: To assess the accuracy of rest and treadmill exercise first-pass radionuclide ventriculographic measurements of left ventricular ejection fraction (LVEF), 40 patients underwent treadmill exercise first-pass and bicycle exercise equilibrium radionuclide ventriculography. To determine the frequency of technically adequate treadmill exercise first-pass studies, an additional 128 consecutive patients undergoing treadmill exercise first-pass procedures during stress 99mTc-labeled sestamibi myocardial perfusion studies were assessed. METHODS AND RESULTS: The treadmill exercise first-pass procedure used a multicrystal camera and an 241Am point source to allow for correction of patient motion. Excellent correlations were observed between resting first-pass and resting equilibrium LVEF (r = 0.91; standard error of the estimate = 5.6). A high correlation was also observed between treadmill exercise first-pass and bicycle equilibrium exercise LVEF measurements (r = 0.85, standard error of the estimate = 7.6). Treadmill first-pass LVEF systematically underestimated the bicycle equilibrium LVEF. Intraobserver agreement for rest and exercise first-pass LVEF was high (r values of 0.98 and 0.94, respectively). Of the 168 consecutive treadmill exercise first-pass studies evaluated for technical adequacy, 21 (12.5%) were deemed technically inadequate, with most of the sources of error being avoidable. The frequency of technically adequate studies was as high (87%) in high levels of exercise (Bruce stages 3 and 4) as in lower levels (88%). The findings of this study validate the first-pass treadmill exercise LVEF measurement. CONCLUSION: This procedure now provides the option for combining the information of peak treadmill exercise LVEF with measurements of exercise myocardial perfusion from the same injection of radioactivity.

Adult↗
PubMedDate not supplied

Diagnostic efficacy of stress technetium 99m-labeled sestamibi myocardial perfusion single-photon emission computed tomography in detection of coronary artery disease among patients over age 80.

BACKGROUND: Because symptoms of myocardial ischemia in elderly patients are often atypical, accurate noninvasive assessment of the presence, extent, and severity of coronary artery disease (CAD) would be especially useful to avoid unnecessary catheterization or invasive intervention. This study assessed the safety and diagnostic efficacy of 99mTc-labeled sestamibi (99mTc-sestamibi) exercise and pharmacologic myocardial perfusion single-photon emission computed tomography (SPECT) with adenosine or dipyridamole in patients age 80 years or older. METHODS AND RESULTS: Stress 99mTc-sestamibi SPECT was performed in 75 consecutive patients who were 80 years old or older (range: 80 to 91 years) with suspected CAD and who underwent coronary angiography within 6 months of the nuclear study. Of these patients, 51 underwent a pharmacologic (adenosine = 42; dipyridamole = 9) stress study and 24 underwent an exercise treadmill study. A normalcy rate was derived from an additional 36 patients (ages 83 +/- 3 years) who had undergone stress 99mTc-sestamibi SPECT and who had a relatively low likelihood (< 20%) of CAD. No serious adverse events occurred during or after the exercise or the pharmacologic stress test. The overall sensitivity and specificity for detecting CAD with > or = 70% stenosis was 95% (52/55) and 75% (15/20), whereas the corresponding results were 87% (55/63) and 83% (10/12) for detecting patients with > or = 50% stenosis. The sensitivity and specificity for pharmacologic stress 99mTc-sestamibi SPECT were 95% (35/37) and 71% (10/14) for detecting > or = 70% stenosis, and 86% (37/43) and 75% (6/8) for detecting CAD with > or = 50% stenosis. The sensitivity and specificity of treadmill testing were 94% (17/18) and 83% (5/6) in detecting CAD with stenosis > or = 70% and 90% (18/20) and 100% (4/4) in detecting CAD with stenosis > or = 50%. The normalcy rate among the low likelihood patients was 83% (30/36). The accuracy of stress sestamibi testing was similar for patients with or without angina. CONCLUSIONS: Our findings suggest that exercise or pharmacologic myocardial perfusion SPECT with 99mTc-sestamibi is safe and diagnostically accurate for CAD detection in very elderly patients, irrespective of symptoms. Pharmacologic myocardial perfusion SPECT with adenosine or dipyridamole appears to be a valuable alternative to treadmill stress in very elderly patients incapable of performing adequate exercise.

Aged↗
PubMedDate not supplied

Repeatability of treadmill exercise ejection fraction and wall motion using technetium 99m-labeled sestamibi first-pass radionuclide ventriculography.

BACKGROUND: Peak treadmill exercise radionuclide ventriculography (RVG) with technetium 99m has recently been validated for determination of left ventricular ejection fraction (LVEF). However, the repeatability of this technique for determination of both LVEF and regional wall motion has not been reported. METHODS AND RESULTS: Each of 27 clinically stable patients underwent two treadmill exercise RVG studies within 40 +/- 51 days. The level of exercise achieved in the two tests was similar (double product: 26,357 +/- 3877 vs 26,621 +/- 4287), and there was no change in clinical or treatment status between the studies. Acquisition and processing were accomplished with a mobile multicrystal camera and a new version of a commercial software (Scinticor SIM 400 V. 4.1 BETA, Milwaukee, Wis.) that uses two left ventricular regions of interest. The two tests were compared to assess agreement (repeatability) on both an automatically calculated LVEF and wall motion in five left ventricular segments (basal anterior, distal anterior, apical, distal inferior, and basal inferior), with a 3-point semiquantitative visual score. Intraobserver and interobserver agreements (reproducibility) also were assessed on quantitative exercise LVEF derived from the same RVG test from a separate group of 20 patients with a broad range of exercise LVEF. The first and second treadmill exercise LVEFs were highly correlated (r = 0.92, SEE = 3.96, y = 0.97x + 0.58; and r = 0.99, SEE = 1.32, y = 0.99x + 0.25, respectively). Results of segmental visual score agreement between the first and the second treadmill first-pass studies were as follows: overall, 86% (116/135, kappa = 0.74); basal anterior, 85% (23/27, kappa = 0.72); distal anterior, 85% (23/27, kappa = 0.84); apical, 93% (25/27, kappa = 0.85); distal inferior, 93% (25/27, kappa = 0.80); and basal inferior, 67% (18/27, kappa = 0.64). CONCLUSION: Treadmill exercise first-pass RVG is a highly repeatable and reproducible test for quantitative LVEF and visual regional wall motion analysis. Our results imply the procedure may be useful for serial follow-up of patients with coronary artery disease and for the evaluation of the efficacy of medical or interventional treatment.

Adult↗
PubMedDate not supplied

Fast technetium 99m-labeled sestamibi gated single-photon emission computed tomography for evaluation of myocardial function.

BACKGROUND: This study assesses the feasibility of 99mTc-labeled sestamibi electrocardiographic gated single-photon emission computed tomography (SPECT) with a short acquisition time (6.7 minutes, "fast" gated SPECT) for the evaluation of stress myocardial perfusion and poststress myocardial function. Simultaneous assessment of stress perfusion and poststress function is possible with standard gated SPECT acquisition (19.3 minutes) of stress-injected sestamibi. Sestamibi gated SPECT can be used to evaluate regional wall motion (RWM), thickening, and left ventricular ejection fraction (LVEF); the feasibility of fast gated SPECT has not been evaluated previously. METHODS AND RESULTS: Fifty patients were studied who underwent treadmill exercise, sestamibi injection (25 to 30 mCi), and standard gated SPECT 15 minutes after exercise, immediately followed by fast gated SPECT. All patients underwent rest 201Tl SPECT before exercise testing. All studies were analyzed by semiquantitative visual scoring. Both standard and fast gated SPECT were read for stress perfusion and poststress wall motion and thickening, dividing the left ventricle into 20 segments, on a 5-point scale described previously. The measurement of LVEF used a previously described automatic algorithm. Average myocardial counts per pixel were 58 +/- 19 for standard gated SPECT and 13 +/- 4 for fast gated SPECT (p = 0.0001). Heart/lung ratio was 10.2 +/- 4.8 for regular gated SPECT and 10.3 +/- 5.7 for fast gated SPECT (difference not significant). Perfusion analysis showed exact agreement in 92% of the segments (kappa = 0.76; p < 0.01). Correlation between LVEFs measured from standard and fast gated SPECT was 0.94. Analysis of 998 segments (two segments were uninterpretable) showed exact agreement in 96% (kappa = 0.89; p < 0.001) for RWM and 94% (kappa = 0.83; p < 0.001) for thickening between standard and fast gated SPECT. In 225 segments with abnormal RWM and 189 segments with abnormal thickening by both standard and fast gated SPECT, exact agreements were 0.92 for RWM (kappa = 0.90; p < 0.001) and 0.87 for thickening (kappa = 0.80; p < 0.01). CONCLUSIONS: Our data demonstrate that fast sestamibi gated SPECT is feasible and yields results equivalent to those of standard sestamibi gated SPECT with respect to left ventricular regional and global function.

Aged↗